A Quick Look at Today's Ratings for Merck & Co(MRK.US), With a Forecast Between $120 to $125
BMO Capital Maintains Outperform on Merck & Co, Lowers Price Target to $136
Merck Is Maintained at Equal-Weight by Morgan Stanley
Goldman Sachs Adjusts Merck & Co.'s Price Target to $135 From $139
A Quick Look at Today's Ratings for Merck & Co(MRK.US), With a Forecast Between $110 to $150
Merck & Co Analyst Ratings
Merck Is Maintained at Buy by Citigroup
Merck & Co Analyst Ratings
Barclays Maintains Merck & Co(MRK.US) With Buy Rating, Maintains Target Price $140
BofA Securities Maintains Merck & Co(MRK.US) With Buy Rating
This Biotech Stock Could Rocket 800%, Analyst Says -- Barrons.com
Wells Fargo Maintains Merck & Co(MRK.US) With Hold Rating, Maintains Target Price $125
Barclays Maintains Merck & Co(MRK.US) With Buy Rating, Maintains Target Price $140
Jefferies Maintains Merck & Co(MRK.US) With Buy Rating, Maintains Target Price $147
Wells Fargo Maintains Merck & Co(MRK.US) With Hold Rating, Maintains Target Price $125
Berenberg Bank Maintains Merck & Co(MRK.US) With Buy Rating, Maintains Target Price $135
Merck & Company (MRK) Receives a Buy From Berenberg Bank
Goldman Sachs Adjusts Price Target on Merck to $139 From $140
Barclays Maintains Merck & Co(MRK.US) With Buy Rating, Maintains Target Price $140
Merck & Co Analyst Ratings